K H Vogelberg - JoVE Visualize

Showing results (21-30 of 31) with videos related to

Pageof 4

Sort By:

Arzneimittel-Forschung|January 1, 1984

[The somatostatin infusion test for the evaluation of glucose utilization in bezafibrate medication]K H Vogelberg, H J Müller, A Hübinger

Arzneimittel-Forschung|January 1, 1982

[The influence of clofibrate on glucose metabolism in diabetes mellitus without endogenous hypertriglyceridemia (author's transl)]K H Vogelberg, R Scherff, B Schulze-Schleppinghoff

Hormone and Metabolic Research. Supplement Series|January 1, 1985

Hypertriglyceridemia in insulin dependent diabetes mellitus with peripheral vascular diseaseK H Vogelberg, K Grimm, F A Gries

Deutsche Medizinische Wochenschrift (1946)|November 9, 1984

[Gallbladder contractility, cholelithiasis and autonomic neuropathy in diabetes mellitus]K H Vogelberg, H G Kübler, J Cicmir, et al.

European Journal of Clinical Pharmacology|January 1, 1982

Effect of neomycin sulphate alone and in combination with D-thyroxine on serum lipoproteins in hypercholesterolaemic subjectsK H Vogelberg, T Koschinsky, H Hein, et al.

MMW, Munchener Medizinische Wochenschrift|August 20, 1976

[The treatment of chronic insulin resistance in adipose diabetics--interruption for a short time of diet and insulin administration (author's transl)]K H Vogelberg, F A Gries, D Grüneklee, et al.

Clinical Genetics|September 1, 1977

Studies on the metabolic defect in Broad-beta disease (hyperlipoproteinaemia type III)G Utermann, H Canzler, M Hees, et al.

Atherosclerosis|September 1, 1975

Primary hyperlipoproteinemias as risk factors in peripheral artery disease documented by arteriographyK H Vogelberg, P Berchtold, H Berger, et al.

Clinical Genetics|January 1, 1979

Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type IIIG Utermann, K H Vogelberg, A Steinmetz, et al.

Medizinische Klinik|September 23, 1977

[Treatment of primary hyperlipoproteinemia type IIb and IV. Comparison of the lipid lowering effect of phenformin, clofibrate, and a combination of both (author's transl)]T Koschinsky, P Lenhard, F A Gries, et al.

Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:

Pageof 4

Arzneimittel-Forschung|January 1, 1984

[The somatostatin infusion test for the evaluation of glucose utilization in bezafibrate medication]K H Vogelberg, H J Müller, A Hübinger

Arzneimittel-Forschung|January 1, 1982

[The influence of clofibrate on glucose metabolism in diabetes mellitus without endogenous hypertriglyceridemia (author's transl)]K H Vogelberg, R Scherff, B Schulze-Schleppinghoff

Hormone and Metabolic Research. Supplement Series|January 1, 1985

Hypertriglyceridemia in insulin dependent diabetes mellitus with peripheral vascular diseaseK H Vogelberg, K Grimm, F A Gries

Deutsche Medizinische Wochenschrift (1946)|November 9, 1984

[Gallbladder contractility, cholelithiasis and autonomic neuropathy in diabetes mellitus]K H Vogelberg, H G Kübler, J Cicmir, et al.

European Journal of Clinical Pharmacology|January 1, 1982

Effect of neomycin sulphate alone and in combination with D-thyroxine on serum lipoproteins in hypercholesterolaemic subjectsK H Vogelberg, T Koschinsky, H Hein, et al.

MMW, Munchener Medizinische Wochenschrift|August 20, 1976

[The treatment of chronic insulin resistance in adipose diabetics--interruption for a short time of diet and insulin administration (author's transl)]K H Vogelberg, F A Gries, D Grüneklee, et al.

Clinical Genetics|September 1, 1977

Studies on the metabolic defect in Broad-beta disease (hyperlipoproteinaemia type III)G Utermann, H Canzler, M Hees, et al.

Atherosclerosis|September 1, 1975

Primary hyperlipoproteinemias as risk factors in peripheral artery disease documented by arteriographyK H Vogelberg, P Berchtold, H Berger, et al.

Clinical Genetics|January 1, 1979

Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type IIIG Utermann, K H Vogelberg, A Steinmetz, et al.

Medizinische Klinik|September 23, 1977

[Treatment of primary hyperlipoproteinemia type IIb and IV. Comparison of the lipid lowering effect of phenformin, clofibrate, and a combination of both (author's transl)]T Koschinsky, P Lenhard, F A Gries, et al.

Pageof 4